FDA Approved: BUDESONIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Budesonide from Chartwell RX, LLC, authorizing a change to an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Chronic Obstructive Pulmonary Disease
• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

SUPPL AP for BUDESONIDE (BUDESONIDE)